Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

PFIZER INC

End-of-day quote Nyse  -  06:52 2022-12-05 pm EST
- USD    0.00%
04:08pPfizer asks FDA to approve updated COVID-19 shot for young children
AQ
11:01aUpdates In Co-Pay Assistance And Accumulators Litigation
AQ
10:50aPfizer asks FDA to clear updated COVID shot for kids under 5
AQ
SummaryNewsRatingsCalendarCompanyFunds 
Business Summary
Pfizer, Inc. the world's leading pharmaceutical group. Net sales break down by family of products as follows:

- vaccines (52.4%);

- drugs for the treatment of cancer (15.2%);

- cardiovascular, metabolic and analgesic drugs (11.5%);

- injectable, anti-infectives drugs and active pharmaceutical ingredients (9%);

- drugs for inflammatory and immune diseases (5.5%);

- drugs for rare diseases (4.4%);

- other (2%).

At the end of 2021, the group had more than 39 production sites worldwide.

Net sales are distributed geographically as follows: the United States (36.6%), Europe (22.6%) and other (40.8%).
Managers
Name Title Age Since
Albert Bourla Chairman, Chief Executive & Operating Officer 59 2020
David Denton Chief Financial Officer & Executive Vice President 56 2022
Mikael Dolsten Executive VP, President-Research & Development 63 2010
Lidia Fonseca Executive VP, Chief Digital & Technology Officer 52 -
Aida Habtezion Chief Medical Officer - -
Annaliesa Anderson, Dr. VP, CSO-Bacterial Research & Hospital - -
Rady Johnson Executive VP, Chief Compliance & Risk Officer 60 2013
Bryan Dunn Investor Relations Contact - -
Christopher J. Stevo Senior Vice President - 2021
Margaret M. Madden Secretary, Chief Governance Counsel & Senior VP - -
Members of the board
Name Title Age Since
Albert Bourla Chairman, Chief Executive & Operating Officer 59 2020
Suzanne Johnson Independent Director 64 2007
Helen H. Hobbs, Dr. Independent Director 68 2011
Shantanu Narayen Lead Independent Director 57 -
James Smith Independent Director 61 2014
Joseph Echevarria Independent Director 64 2015
Ronald E. Blaylock Independent Director 61 2017
Dan R. Littman, Dr. Independent Director 68 2018
James R. Quincey Independent Director 56 2020
Susan J. Hockfield, Dr. Independent Director 70 2020
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 9,516,314,537 5,610,756,746 59.0% 3,903,000,000 41.0% 59.0%
Shareholders
NameEquities%
The Vanguard Group, Inc. 470,112,034 8.38%
SSgA Funds Management, Inc. 287,612,741 5.12%
Capital Research & Management Co. (World Investors) 248,850,529 4.43%
Wellington Management Co. LLP 210,874,152 3.76%
Capital Research & Management Co. 142,320,700 2.54%
BlackRock Fund Advisors 121,369,861 2.16%
Geode Capital Management LLC 110,442,140 1.97%
Charles Schwab Investment Management, Inc. 70,123,906 1.25%
Northern Trust Investments, Inc.(Investment Management) 66,587,775 1.19%
Norges Bank Investment Management 56,763,604 1.01%
Holdings
NameEquities%Valuation
PFIZER LIMITED (500680) 29,243,042 63.9% 1,547,158,406 USD
AKERO THERAPEUTICS, INC. (AKRO) 2,525,252 5.44% 106,717,150 USD
VALNEVA SE (VLA) 9,549,761 6.90% 64,615,975 USD
SPRINGWORKS THERAPEUTICS, INC. (SWTX) 2,340,330 3.75% 56,191,323 USD
SOSEI GROUP CORPORATION (4565) 1,885,136 2.30% 25,784,513 USD
BIOATLA, INC. (BCAB) 1,372,052 3.78% 9,453,438 USD
WAVE LIFE SCIENCES LTD. (WVE) 1,875,000 2.16% 8,981,250 USD
NEXTCURE, INC. (NXTC) 1,970,759 7.10% 4,926,898 USD
SPERO THERAPEUTICS, INC. (SPRO) 2,362,348 6.74% 4,630,202 USD
4D MOLECULAR THERAPEUTICS, INC. (FDMT) 341,658 1.06% 2,958,758 USD
Company contact information
Pfizer Inc.
235 East 42nd Street
New York, NY 10017-5755

Phone : +1.212.733.2323
Web : http://www.pfizer.com
Sector Other Pharmaceuticals
1st jan.Capi. (M$)
PFIZER INC285 774
JOHNSON & JOHNSON4.57%467 679
ELI LILLY AND COMPANY35.67%356 089
ABBVIE INC.20.87%289 331
NOVO NORDISK A/S22.04%285 887
PFIZER, INC.-13.78%285 774
MERCK & CO., INC.43.58%278 995
ROCHE HOLDING AG-18.69%270 669
ASTRAZENECA PLC28.81%212 164
NOVARTIS AG4.81%192 650
BRISTOL-MYERS SQUIBB COMPANY30.12%180 080
AMGEN INC.26.91%152 342
SANOFI-3.17%112 783
GILEAD SCIENCES, INC.22.61%111 665
GSK PLC-13.36%70 368
DAIICHI SANKYO CO., LTD.50.60%62 399
BAYER AG16.68%56 492
TAKEDA PHARMACEUTICAL COMPANY LIMITED26.46%45 571
CHUGAI PHARMACEUTICAL CO., LTD-4.42%43 395
JIANGSU HENGRUI MEDICINE CO., LTD.-21.36%36 798
ASTELLAS PHARMA INC.11.44%28 074